live

UKNI MVS Operating normally
+44 (0) 20 3855 0656
MENU

live

UKNI MVS Operating normally

How can we help?

Quick Links

Scanner Check Packs

End User Registration Guidance

How to progress the analysis of an alert?

How to register as an MAH

First Login - Quick Start Guide

Two Year Certificate Expiry

List of Software Suppliers

Useful FMD Links

I am a Community Pharmacist. Where can I find information on the FMD that is tailored to my sector?

For more information, please visit the NHS Digital FMD Toolkit for Community Pharmacy.

FMD Source, the website of the UK FMD Working Group for Community Pharmacy, is also a useful guide.

Community Pharmacy Northern Ireland (CPNI) also have some useful information.

Related articles

Will Community/Hospital Pharmacies be able to return stock to their Wholesaler or a DTP manufacturer’s distributor?

This depends upon the terms and conditions of both the Wholesaler and the manufacturer. However, in general, we expect the current returns process will remain valid as long as the stock has not been decommissioned and the anti-tamper device is still intact.

Is aggregation permitted, in particular for use of downstream wholesalers?

The Delegated Regulation allows for aggregation but does not stipulate the need for pack aggregation. The EMVS / NMVS system does not support aggregation.

Where can I find a copy of the Delegated Regulation?

You can find the Delegated Regulation here.

Where can I get more information of the safety features aspects of FMD?

Please consult the UK government website.

Which medicines are in scope of FMD?

For details of the scope of the regulation please check: FMD Delegated Regulation 2016_161

Where stakeholders are unclear on the legislation, for example whether types of medicine are in/out of scope, please contact DHSC/MHRA at fmd. safetyfeatures@mhra. gov. uk.

Will anti-tamper devices be allowed on OTCs and other out-of-scope products after February 2019?

The MHRA has confirmed that subject to the outcome of a public consultation anti-tamper devices may continue to be placed on out-of-scope products after 9th February 2019 if the relevant manufacturer considers that it is necessary to do so in the interests of patient safety.